1 Jeyaseelan K, Lim KY, Armugam A. Neuroprotectants

in stroke therapy[J]. Expert Opin Pharmacother, 2008,

9:887-900.

2 Tuttolomondo A, Di Sciacca R, Di Raimondo D, et

al. Neuron protection as a therapeutic target in acute

ischemic stroke[J]. Curr Top Med Chem, 2009, 9:1317-

1334.

3 Hazell AS. Excitotoxic mechanisms in stroke:an

update of concepts and treatment strategies[J].

Neurochem Int, 2007, 50:941-953.

4 Bano D, Nicotera P. Ca2+ signals and neuronal death in

brain ischemia[J]. Stroke, 2007, 38:674-676.

5 Allen CL, Bayraktutan U. Oxidative stress and its role

in the pathogenesis of ischaemic stroke[J]. Int J Stroke,

2009, 4:461-470.

6 Grotta J. Lubeluzole treatment of acute ischemic

stroke. The US and Canadian Lubeluzole Ischemic

Stroke Study Group[J]. Stroke, 1997, 28:2338-2346.

7 Dyker AG, Lees KR. Duration of neuroprotective

treatmemt for ischemic stroke[J]. Stroke, 1998,

29:535-542.

8 Zivin JA. Factors determining therapeutic window for

stroke[J]. Neurology, 1998, 50:599-603.

9 Thompson CB. Apoptosis in the pathogenesis and

treatment of disease[J]. Science, 1995, 267:1456-1462.

10 Jacobson MD, Raff MC. Programmed cell death and

Bcl-2 protection in very low oxygen[J]. Nature, 1995,

374:814-816.

11 Shao W, Zhang SZ, Tang M, et al. Suppression

of neuroinf lammation by astrocytic dopamine D2

receptors via αB-crystallin[J]. Nature, 2013, 494:90-94.

12 Zhao Y, Rempe DA. Targeting astrocytes for stroke

therapy[J]. Neurotherapeutics, 2010, 7:439-451.

13 Li Y, Liu Z, Xin H, et al. The role of astrocytes in

mediating exogenous cell-based restorative therapy

for stroke[J]. Glia, 2014, 62:1-16.

14 Hines DJ, Haydon PG. Inhibition of a SNAREsensitive

pathway in astrocytes attenuates damage

following stroke[J]. J Neurosci, 2013, 33:4234-4240.

15 Jiang P, Chen C, Wang R, et al. hESC-derived Olig2+

progenitors generate a subtype of astroglia with

protective effects against ischaemic brain injury[J].

Nat Commun, 2013, 4:2196.

16 Rajendran P, Rengarajan T, Thangavel J, et al. The

vascular endothelium and human diseases[J]. Int J Bio Sci, 2013, 9:1057-1069.

17 Zhao YH, Yuan B, Chen J, et al. Endothelial

progenitor cells:therapeutic perspective for ischemic

stroke[J]. CNS Neurosci Ther, 2013, 19:67-75.

18 Shah K, Abbruscato T. The role of blood-brain barrier

transporters in pathophysiology and pharmacotherapy

of stroke[J]. Curr Pharm Des, 2014, 20:1510-1522.

19 Nor abe rg J, Poul sen FR, Bla abje rg M, et a l.

Organotypic hippocampal slice cultures for studies

of brain damage, neuroprotection and neurorepair[J].

Curr Drug Targets CNS Neurol Disord, 2005, 4:435-

452.

20 Lo EH, Dalkara T, Moskowitz MA. Mechanisms,

challenges and opportunities in stroke[J]. Nat Rev

Neurosci, 2003, 4:399-414.

21 Pacifici M, Peruzzi F. Isolation and culture of rat

embryonic neural cells:a quick protocol[J]. J Vis Exp,

2012, 24:e3965.

22 McCarthy KD, de Vellis J. Preparation of separate

astroglial and oligodendroglial cell cultures from rat

cerebral tissue[J]. J Cell Biol, 1980, 85:890-902.

23 Chen Z, Rubin J, Tzima E. Role of PECAM-1 in

ar teriogenesis and specif ication of preexisting

collaterals[J]. Circ Res, 2010, 107:1355-1363.

24 Sajja RK, Prasad S, Cucullo L. Impact of altered

glycaemia on blood-brain barrier endothelium:an in

vitro study using the hCME/D3 cell line[J]. Fluids

Barriers CNS, 2014, 11:8.

25 Adamchik Y, Frantseva MV, Weisspapir M, et al.

Methods to induce primary and secondary traumatic

damage in organotypic hippocampal slice cultures[J].

Brain Res Brain Res Protoc, 2000, 5:153-158.

26 Xue Q, Liu Y, Qi H, et al. A novel brain neurovascular

unit model with neurons, astrocytes and microvascular

endothelial cells of rat[J]. Int J Bio Sci, 2013, 9:174-189.